Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride.
Standl
Eberhard
E
Munich Diabetes Research Institute, 3 Medical Department, Krankenhaus München-Schwabing, Kölner Platz 1, D-80804, Münich, Germany. eberhard.standl@lrz.uni-muenchen.de
Maxeiner
Stephan
S
Raptis
Sotirios
S
Karimi-Anderesi
Zahra
Z
Schweitzer
Matthias Axel
MA
D001786:Blood Glucose / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015994:Incidence; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D013453:Sulfonylurea Compounds; D000069036:Insulin Glargine; C057619:glimepiride